| Lin MC |
------>authors3_c= ------>paper_class1=2 ------>Impact_Factor=None ------>paper_class3=0 ------>paper_class2=0 ------>vol=P707 ------>confirm_bywho=amel ------>insert_bywho=ywcheng ------>Jurnal_Rank=None ------>authors4_c= ------>comm_author=1 ------>patent_EDate=None ------>authors5_c= ------>publish_day=1 ------>paper_class2Letter=None ------>page2= ------>medlineContent= ------>unit=G0100 ------>insert_date=20090318 ------>iam=7 ------>update_date=None ------>author=??? ------>change_event=4 ------>ISSN= ------>authors_c= ------>score=415 ------>journal_name=The Twenty-two Joint Annual Conference of biomedical Science (Abstract) ------>paper_name=Podophyllin, but not the constitute of quercetin and kaemperol, induced genotoxicity in vitro and in vivo through ROS production ------>confirm_date=20090318 ------>tch_id=089070 ------>pmid=19514941 ------>page1= ------>fullAbstract=The genotoxic potential of podophyllin (PD) was investigated in this study. PD increased bacterial revertants and abnormal chromosomal structures in a concentration-dependent manner, both with and without metabolic activating enzymes, and increased the incidence of micronuclei in imprinted control region mouse reticulocytes. Results from three studied constituents of PD, such as podophyllotoxin, kampferol, and quercetin, suggested that the mutagenic effect of PD was not due to the presence of podophyllotoxin, kampferol, and quercetin and might be related to other components and the formation of reactive oxygen species. The detailed mutagenic mechanisms need further investigation, and the medicinal use of PD needs to be cautioned against. ------>tmu_sno=None ------>sno=21638 ------>authors2=Cheng HW ------>authors3=Lin JH ------>authors4=Chen SK ------>authors5=Tsai YC ------>authors6=Liao PL, Cheng YW ------>authors6_c= ------>authors=Lin MC ------>delete_flag=0 ------>SCI_JNo=None ------>authors2_c= ------>publish_area=1 ------>updateTitle=Podophyllin, but not the constituents quercetin or kaempferol, induced genotoxicity in vitro and in vivo through ROS production. ------>language=2 ------>check_flag=None ------>submit_date=None ------>country=None ------>no= ------>patent_SDate=None ------>update_bywho=None ------>publish_year=2007 ------>submit_flag=None ------>publish_month=1 |